PMID- 27731349 OWN - NLM STAT- MEDLINE DCOM- 20180425 LR - 20201019 IS - 2045-2322 (Electronic) IS - 2045-2322 (Linking) VI - 6 DP - 2016 Oct 12 TI - TRPM2 regulates TXNIP-mediated NLRP3 inflammasome activation via interaction with p47 phox under high glucose in human monocytic cells. PG - 35016 LID - 10.1038/srep35016 [doi] LID - 35016 AB - Excessive production of reactive oxygen species (ROS) induced by hyperglycemia increased the secretion of interleukin-1beta (IL-1beta), which contributes to the pathogenesis of diabetes and its complications. Although high glucose (HG)-induced oxidative stress and aberrant Ca(2+) channels activity causes an increase in transmembrane Ca(2+) influx, however the relative contribution of Transient receptor potential (TRP) channels is not well studied. Here, we identified that HG (30 mM glucose for 48 h) induced the activation of the NLRP3-ASC inflammasome, leading to caspase-1 activation, and IL-1beta and IL-18 secretion in human monocytic cell lines. Moreover, we used a hyperglycemia model in U937 monocytes, showing that the activation of TRPM2 was augmented, and TRPM2-mediated Ca(2+) influx was critical for NLRP3 inflammasome activation. This pathway involved NADPH oxidase-dependent ROS production and TXNIP-NLRP3 inflammasome pathway. Furthermore, the inhibition of TRPM2 reduced ROS production and lowered NADPH oxidase activity via cooperatively interaction with p47 phox in response to HG. These results provided a mechanistic linking between TRPM2-mediated Ca(2+) influx and p47 phox signaling to induce excess ROS production and TXNIP-mediated NLRP3 inflammasome activation under HG, and suggested that TRPM2 represented a potential target for alleviating NLRP3 inflammasome activation related to hyperglycemia-induced oxidative stress in Type 2 diabetes Mellitus (T2DM). FAU - Tseng, Hisa Hui Ling AU - Tseng HH AD - State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Avenida da Universidade, Taipa, Macau, China. FAU - Vong, Chi Teng AU - Vong CT AD - State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Avenida da Universidade, Taipa, Macau, China. FAU - Kwan, Yiu Wa AU - Kwan YW AD - School of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, N.T., Hong Kong, China. FAU - Lee, Simon Ming-Yuen AU - Lee SM AD - State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Avenida da Universidade, Taipa, Macau, China. FAU - Hoi, Maggie Pui Man AU - Hoi MP AD - State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Avenida da Universidade, Taipa, Macau, China. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20161012 PL - England TA - Sci Rep JT - Scientific reports JID - 101563288 RN - 0 (Carrier Proteins) RN - 0 (IL18 protein, human) RN - 0 (IL1B protein, human) RN - 0 (Inflammasomes) RN - 0 (Interleukin-18) RN - 0 (Interleukin-1beta) RN - 0 (NLR Family, Pyrin Domain-Containing 3 Protein) RN - 0 (NLRP3 protein, human) RN - 0 (Reactive Oxygen Species) RN - 0 (TRPM Cation Channels) RN - 0 (TRPM2 protein, human) RN - 0 (TXNIP protein, human) RN - EC 1.6.3.- (NADPH Oxidases) RN - EC 1.6.3.1 (neutrophil cytosolic factor 1) RN - EC 3.4.22.36 (Caspase 1) RN - IY9XDZ35W2 (Glucose) SB - IM MH - Carrier Proteins/*metabolism MH - Caspase 1/metabolism MH - Cell Line MH - Gene Expression Regulation/drug effects MH - Glucose/*pharmacology MH - Humans MH - Hyperglycemia/metabolism MH - Inflammasomes/metabolism MH - Interleukin-18/metabolism MH - Interleukin-1beta/metabolism MH - Models, Biological MH - Monocytes/cytology/*drug effects/metabolism MH - NADPH Oxidases/*metabolism MH - NLR Family, Pyrin Domain-Containing 3 Protein/*metabolism MH - Reactive Oxygen Species/metabolism MH - TRPM Cation Channels/*metabolism PMC - PMC5059733 EDAT- 2016/10/13 06:00 MHDA- 2018/04/26 06:00 PMCR- 2016/10/12 CRDT- 2016/10/13 06:00 PHST- 2016/07/07 00:00 [received] PHST- 2016/09/21 00:00 [accepted] PHST- 2016/10/13 06:00 [entrez] PHST- 2016/10/13 06:00 [pubmed] PHST- 2018/04/26 06:00 [medline] PHST- 2016/10/12 00:00 [pmc-release] AID - srep35016 [pii] AID - 10.1038/srep35016 [doi] PST - epublish SO - Sci Rep. 2016 Oct 12;6:35016. doi: 10.1038/srep35016.